Oragenics (OGEN), Intrexon (XON) Terminate Collaboration Agreement for Development and Commercialization of Probiotics
Tweet Send to a Friend
On September 30 2015, Oragenics (NYSE: OGEN) and Intrexon (NYSE: XON) mutually agreed to terminate the Exclusive Channel ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
